© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Predictive Oncology Inc. (POAI) shows an Average True Range (ATR) of 0.92 and an Enterprise Value of -427.63K. Its average trading volume over the past 3 months is 53.35K, indicating liquidity. These fundamental metrics provide insight into POAI's underlying financial health and market activity.
Predictive Oncology Inc. (POAI) technical indicators as of January 1, 2026: the SMA 20 is 2.1%, SMA 50 at -29.3%, and SMA 200 at -55.15%. The RSI 14 value is 44.7, suggesting its current momentum. These technical analysis signals help assess POAI's price trends and potential future movements.
Predictive Oncology Inc. (POAI) stock performance overview as of January 1, 2026: The 52-week high is $45.9 (currently -87.04% below), and the 52-week low is $3.88 (currently 53.35% above). Over the past year, POAI's performance is -50.6%, compared to the S&P 500's 12.29% change.
According to market data, Predictive Oncology Inc. (POAI) stock's recent performance metrics show that over the last month, POAI is -9.16%, with a Year-to-Date (YTD) performance of -51.63%. Over the past year, the stock has seen a -50.6% change. These figures summarize POAI's price movements across various periods, reflecting its historical returns.
According to current financial data, POAI stock's P/E (TTM) ratio is -0.05, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for POAI, including P/S (5.93), P/B (-0.06), and P/FCF (-0.49), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.